Literature DB >> 29233947

Reply to Mohlin et al.: High levels of EPAS1 are closely associated with key features of low-risk neuroblastoma.

Isabelle Westerlund1, Yao Shi1, Konstantinos Toskas1, Stuart M Fell1, Shuijie Li1,2, Erik Södersten1, Susanne Schlisio1,2, Johan Holmberg3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29233947      PMCID： PMC5754814          DOI： 10.1073/pnas.1718429115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

1.  No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms.

Authors:  Sofie Mohlin; Kristoffer von Stedingk; Alexander Pietras; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-12       Impact factor: 11.205

2.  Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.

Authors:  Isabelle Westerlund; Yao Shi; Konstantinos Toskas; Stuart M Fell; Shuijie Li; Olga Surova; Erik Södersten; Per Kogner; Ulrika Nyman; Susanne Schlisio; Johan Holmberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

3.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

Authors:  Linda Holmquist-Mengelbier; Erik Fredlund; Tobias Löfstedt; Rosa Noguera; Samuel Navarro; Helén Nilsson; Alexander Pietras; Johan Vallon-Christersson; Ake Borg; Katarina Gradin; Lorenz Poellinger; Sven Påhlman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

4.  HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts.

Authors:  Sofie Mohlin; Arash Hamidian; Sven Påhlman
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

5.  Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.

Authors:  Hai-Xiang Sun; Yang Xu; Xin-Rong Yang; Wei-Min Wang; Haibo Bai; Ruo-Yu Shi; Suresh K Nayar; Ranjan P Devbhandari; Yi-zhou He; Qin-Feng Zhu; Yun-Fan Sun; Bo Hu; Mehtab Khan; Robert A Anders; Jia Fan
Journal:  Hepatology       Date:  2013-02-07       Impact factor: 17.425

6.  Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.

Authors:  Shahab Asgharzadeh; Jill A Salo; Lingyun Ji; André Oberthuer; Matthias Fischer; Frank Berthold; Michael Hadjidaniel; Cathy Wei-Yao Liu; Leonid S Metelitsa; Roger Pique-Regi; Peter Wakamatsu; Judith G Villablanca; Susan G Kreissman; Katherine K Matthay; Hiroyuki Shimada; Wendy B London; Richard Sposto; Robert C Seeger
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

7.  HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells.

Authors:  Alexander Pietras; Loen M Hansford; A Sofie Johnsson; Esther Bridges; Jonas Sjölund; David Gisselsson; Matilda Rehn; Siv Beckman; Rosa Noguera; Samuel Navarro; Jörg Cammenga; Erik Fredlund; David R Kaplan; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-16       Impact factor: 11.205

8.  High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.

Authors:  A Pietras; D Gisselsson; I Ora; R Noguera; S Beckman; S Navarro; S Påhlman
Journal:  J Pathol       Date:  2008-03       Impact factor: 7.996

9.  Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.

Authors:  Guoliang Qing; Nicolas Skuli; Patrick A Mayes; Bruce Pawel; Daniel Martinez; John M Maris; M Celeste Simon
Journal:  Cancer Res       Date:  2010-10-20       Impact factor: 12.701

10.  Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.

Authors:  Michael S Nakazawa; T S Karin Eisinger-Mathason; Navid Sadri; Joshua D Ochocki; Terence P F Gade; Ruchi K Amin; M Celeste Simon
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.